ClinicalTrials.gg
RecruitingNCT07377513Updated May 12, 2026

Follow-up Compliance for Corneal Ulcer Patients With SMS Reminder

An interventional study of SMS reminder in Corneal Ulcer, sponsored by Seva Canada Society. Recruiting at 1 site in Nepal. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-05-12.

Sponsored by Seva Canada Society · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Started Feb 2026; still recruiting 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
310
Allocation
Non-randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

Corneal ulcer is defined as the loss of corneal epithelium with underlying stromal infiltration and suppuration, accompanied by signs of inflammation, with or without hypopyon1. The condition may be caused by bacterial, fungal, viral or parasitic pathogens and carries a significant risk of corneal perforation and subsequent visual impairment2. These risks highlight the importance of timely treatment plans and consistent referral networks3.

A lot of patients choose to self-medicate and postpone seeking professional assistance due either their lack of awareness or forgetfulness, which results in inadequate follow-up compliance4,5. Scheduling appointments regularly is still a significant barrier to successful treatment and visual recovery.

SMS reminders have shown encouraging real-world success in improving follow-up attendance with in ophthalmology. Mobile health tools, such as the peek Community Eye Health system, have proven increased follow-up rates and improved access to eye care services in low-resource setting through automated appointment reminders and patient monitoring6.

The aim of this operational research study to evaluated the feasibility, scalability, and effectiveness of SMS reminders in improving follow-up compliance among patients with corneal ulcer at the Lumbini Eye Institute and Research Center (LEIRC), Western Nepal. The findings are expected to inform the integration of cost-effective digital health strategies to strengthen patient adherence, optimize clinical outcomes, and support eye health programs in resource limited environments.

Read the detailed description

Corneal ulcer is defined as a loss of the corneal epithelium with underlying stromal infiltration and suppuration associated with the signs of inflammation with or without hypopyon1 The causative agent can be bacterial, fungal, viral, or parasitic. The causative agents of the corneal ulcer may vary depending upon the mode of injury. Fungal keratitis is endemic in tropical regions, accounting for as many as half of all corneal ulcer2 Collagenolytic and inflammatory substance, along with increased corneal matrix, metalloproteinase (MMP) activity, can lead to degradation of corneal collagen and may cause complication such as, scarring, thinning, and corneal perforation. MMPS is over-expressed in infective keratitis. Corticosteroid or tetracyclines, particular doxycycline, are used as adjuvants to antimicrobials, which help to reduce the excessive deterioration and inflammation of the corneal layers caused by corneal MMPs and reduce the inflammatory cell recruitment and infiltration3.

Corneal ulcers have a higher risk of corneal perforation. As a result, standardized referral and treatment protocols for patients with corneal ulcers are required. Potentially sight threatening corneal ulcers are at significantly higher risk for best spectacle corrected visual acuity (BSCVA) loss compared to rarely sight threatening corneal ulcers.7 Most patients use self-medication, and had delayed seeking of professional medical care4 due to a lack of awareness or simply forgetting. These factors may have contributed to the low rate of follow-up visits. Continuous education of patients and professionals is required to reduce the rate and severity of infective keratitis5. . It is a potentially vision threatening ocular emergency8 In developing countries, the average cost for accessing and receiving care for patients with corneal ulcers is US$85.8 ± 4.6 (95% confidence interval: US$76.4, 94.6). The mean total cost to diagnose and appropriately treat 1 case of keratitis such that the patient had vision better than 6/18 at final follow-up was US$56.2 ± 3.6 (95% confidence interval: US$49.0, 63.3)6 SMS reminders have demonstrated real-world success in improving follow-up adherence in ophthalmology. A study in a London ophthalmology outpatient clinic found that sending SMS reminders reduced non-attendance by 38% (relative risk of non-attendance = 0.62; 95% CI 0.48-0.80) compared to no reminder9. Additionally, broader evidence supports that SMS reminders significantly enhance follow-up adherence across healthcare contexts-meta-analysis shows pooled odds ratio (OR) for SMS improving follow-up is 1.76 (95% CI 1.37-2.26; p \< 0.01) compared to controls10.In ophthalmology programs in low-resource areas, mobile health tools integrating SMS reminders have shown promising improvements. For example, the Peek Community Eye Health system, which used SMS to remind referred patients about follow-up appointments, demonstrated improved access to eye care services in rural settings11 through better attendance and tracking. Similar study protocol was designed by Bharatpur Eye Hospital to find out if counseling and reminder using SMS text messages and phone calls would boost the follow-up rates of \<16 paediatric patients. 10

Given the high burden of corneal ulcers, potential for severe complications from poor follow-up, and promising evidence for SMS-based reminder systems in eye care adherence, it is necessary to study further to find the usefulness of reminder system in corneal ulcer patients. This operational research study thus aims to evaluate the feasibility, scalability, and effectiveness of SMS reminders in improving follow-up compliance among corneal ulcer patients at the Lumbini Eye Institute and Research Center, Western Nepal. The findings could catalyze the implementation of the cost-effective digital health strategies for improving outcomes in eye health across resource-limited environments.

Research objectives:

Primary objective:

  • To evaluate the effectiveness of addition of SMS-based reminder system to the routine counselling versus routine counselling alone in improving follow-up compliance among corneal ulcer patients at a tertiary eye care center in western Nepal.

Secondary objectives:

  • To estimate the cost-effectiveness of implementing SMS-based reminders for improving compliance.
02

Conditions studied

  • Corneal Ulcer

Browse trials for

Keywords

  • Corneal ulcer
  • Follow-up compliance
  • SMS reminder
03

In context

Corneal Ulcer

63 studies on the registry are indexed under Corneal Ulcer; 8 are open to participants now.

This study's planned enrollment of 310 is above the median of 60 across 45 interventional studies indexed under Corneal Ulcer.

Browse Corneal Ulcer studies →

Lead sponsor

Seva Canada Society is the lead sponsor of 10 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Newly diagnosed patients (18 to 70 years) of corneal ulcer in one or both eye, who are medically managed, visiting the OPD at LEIRC and have access to a mobile phone.

Exclusion criteria

Exclusion Criteria:

  • Less than 18 years or more than 70 years Patients who do not have a access to a mobile phone.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
310 participants (estimated)

Study arms

  • Experimental
    SMS reminder group

    Other: SMS reminder

  • No intervention
    Control group

Interventions

  • OtherSMS reminder

    Patients presenting on Monday, Wednesday, and Friday for the first time for treatment will be recruited in the intervention group. For those who are recruited after receiving informed consent, SMS reminders before scheduled follow-up will be sent from the hospital regarding the next scheduled visit. In addition, routine counselling will be done during the first visit regarding the follow-up schedule.

06

What researchers measure

Primary outcomes

  1. Follow-up compliance

    Proportion of patients who comply with scheduled follow-up visits during the study period

    Time frame: 6 months

Secondary outcomes

  1. Cost effectiveness

    Direct and indirect cost of the SMS and routine counselling services.

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
  • Lumbini Eye Institute & Research Center
    Siddharthanagar, Lumbini, Nepal
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07377513
Lead sponsor
Seva Canada Society
Collaborators
Lumbini Eye Institute and Research Centre, Pragyaan Sustainable Health Outcomes Foundation
Responsible party
Sponsor
First posted
Jan 30, 2026
Start date
Feb 23, 2026
Primary completion
Jun 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
May 12, 2026

Study contacts

Saraswati Khadka Thapa
Contact
research@lei.org.np, sarukhadkathapa555@gmail.com
+9779847110218 / 071-573827

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion